(Q77360259)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9757147%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

title

Ketoconazole inhibition of triazolam and alprazolam clearance: differential kinetic and dynamic consequences (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9757147%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9757147%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

4

Harmatz JS

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9757147%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

1

Greenblatt DJ

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9757147%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

3

von Moltke LL

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9757147%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

author name string

Wright CE

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9757147%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

Ehrenberg BL

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9757147%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

Harrel LM

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9757147%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

Corbett K

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9757147%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

Counihan M

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9757147%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

Tobias S

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9757147%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

publication date

1 September 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9757147%20AND%20SRC:MED&resulttype=core&format=json

Clinical Pharmacology & Therapeutics

5 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9757147%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

volume

64

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9757147%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9757147%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

page(s)

237-247

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9757147%20AND%20SRC:MED&resulttype=core&format=json

Clinical pharmacokinetics of alprazolam. Therapeutic implications

5 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990172-2

Inhibitors of alprazolam metabolism in vitro: effect of serotonin-reuptake-inhibitor antidepressants, ketoconazole and quinidine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990172-2

Inhibition of human cytochrome P450-3A isoforms by fluoxetine and norfluoxetine: in vitro and in vivo studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990172-2

Population study of triazolam pharmacokinetics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990172-2

Triazolam Pharmacokinetics After Intravenous, Oral, and Sublingual Administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990172-2

Pharmacokinetics and pharmacodynamics of alprazolam after oral and IV administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990172-2

Comparison of alprazolam plasma levels in normal Asian and Caucasian male volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990172-2

Oral triazolam is potentially hazardous to patients receiving systemic antimycotics ketoconazole or itraconazole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990172-2

Commentary: a physiological approach to hepatic drug clearance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990172-2

Presystemic extraction: mechanisms and consequences

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990172-2

The importance of presystemic extraction in clinical psychopharmacology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990172-2

Distinguishing a benzodiazepine agonist (triazolam) from a nonagonist anxiolytic (buspirone) by electroencephalography: kinetic-dynamic studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990172-2

Pharmacokinetic and electroencephalographic study of intravenous diazepam, midazolam, and placebo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990172-2

Dose-dependent pharmacokinetics and psychomotor effects of caffeine in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990172-2

Sensitivity to triazolam in the elderly.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990172-2

Sedative effects and impaired learning and recall after single oral doses of lorazepam.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990172-2

Gas chromatographic analysis of alprazolam in plasma: replicability, stability and specificity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990172-2

Electron-capture gas chromatographic analysis of the triazolobenzodiazepines alprazolam and triazolam

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990172-2

In vitro approaches to predicting drug interactions in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990172-2

Clinical pharmacokinetics of ketoconazole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990172-2

Oral azole drugs as systemic antifungal therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990172-2

The clinician and drug interactions--an update

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990172-2

Metabolism of drugs by cytochrome P450 3A isoforms. Implications for drug interactions in psychopharmacology.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990172-2

Relationship of in vitro data on drug metabolism to in vivo pharmacokinetics and drug interactions: implications for diazepam disposition in humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990172-2

Use of in vitro and in vivo data to estimate the likelihood of metabolic pharmacokinetic interactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990172-2

Pharmacokinetic-pharmacodynamic relationships for benzodiazepines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990172-2

Electroencephalogram effect measures and relationships between pharmacokinetics and pharmacodynamics of centrally acting drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990172-2

10.1016/S0009-9236(98)90172-2

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9757147%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

1 reference